These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8462410)

  • 101. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study.
    Schiff DM; Halvorson AE; Dupont W; Davis MM; Patrick SW
    Subst Abus; 2022; 43(1):551-555. PubMed ID: 34586979
    [No Abstract]   [Full Text] [Related]  

  • 102. Virtual Engagement in a Social Media Community of Mothers With Substance Use Disorders: Content Analysis.
    Mazel S; Zisman-Ilani Y; Hennig S; Garnick D; Nicholson J
    JMIR Form Res; 2021 Jun; 5(6):e24353. PubMed ID: 34184993
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments.
    Faherty LJ; Heins S; Kranz AM; Patrick SW; Stein BD
    Addiction; 2022 Jan; 117(1):162-171. PubMed ID: 34096671
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Consensus Guidelines and State Policies: The Gap Between Principle and Practice at the Intersection of Substance Use and Pregnancy.
    Faherty LJ; Stein BD; Terplan M
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100137. PubMed ID: 33089133
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Perinatal Substance Abuse: At the Clinical Crossroads of Policy and Practice.
    House SJ; Coker JL; Stowe ZN
    Am J Psychiatry; 2016 Nov; 173(11):1077-1080. PubMed ID: 27798997
    [No Abstract]   [Full Text] [Related]  

  • 107. The role of screening, brief intervention, and referral to treatment in the perinatal period.
    Wright TE; Terplan M; Ondersma SJ; Boyce C; Yonkers K; Chang G; Creanga AA
    Am J Obstet Gynecol; 2016 Nov; 215(5):539-547. PubMed ID: 27373599
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness.
    Terplan M; Kennedy-Hendricks A; Chisolm MS
    Subst Abuse; 2015; 9(Suppl 2):1-4. PubMed ID: 26448685
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Validity of Self-Reported Drug Use Information Among Pregnant Women.
    Garg M; Garrison L; Leeman L; Hamidovic A; Borrego M; Rayburn WF; Bakhireva L
    Matern Child Health J; 2016 Jan; 20(1):41-47. PubMed ID: 26175273
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.
    Ross EJ; Graham DL; Money KM; Stanwood GD
    Neuropsychopharmacology; 2015 Jan; 40(1):61-87. PubMed ID: 24938210
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.
    Kwiatkowski MA; Roos A; Stein DJ; Thomas KG; Donald K
    Metab Brain Dis; 2014 Jun; 29(2):245-54. PubMed ID: 24370774
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.
    Wu M; Lagasse LL; Wouldes TA; Arria AM; Wilcox T; Derauf C; Newman E; Shah R; Smith LM; Neal CR; Huestis MA; Dellagrotta S; Lester BM
    Matern Child Health J; 2013 Apr; 17(3):566-75. PubMed ID: 22588827
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Making lemonade out of lemons: a case report and literature review of external pressure as an intervention with pregnant and parenting substance-using women.
    Davis KJ; Yonkers KA
    J Clin Psychiatry; 2012 Jan; 73(1):51-6. PubMed ID: 22316576
    [No Abstract]   [Full Text] [Related]  

  • 114. Initial feasibility of a woman-focused intervention for pregnant african-american women.
    Jones HE; Berkman ND; Kline TL; Ellerson RM; Browne FA; Poulton W; Wechsberg WM
    Int J Pediatr; 2011; 2011():389285. PubMed ID: 21541069
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Making the case for laws that improve health: a framework for public health law research.
    Burris S; Wagenaar AC; Swanson J; Ibrahim JK; Wood J; Mello MM
    Milbank Q; 2010 Jun; 88(2):169-210. PubMed ID: 20579282
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care.
    Roberts SC; Pies C
    Matern Child Health J; 2011 Apr; 15(3):333-41. PubMed ID: 20232126
    [TBL] [Abstract][Full Text] [Related]  

  • 117. External pressure, motivation, and treatment outcome among pregnant substance-using women.
    Ondersma SJ; Winhusen T; Lewis DF
    Drug Alcohol Depend; 2010 Mar; 107(2-3):149-53. PubMed ID: 19926408
    [TBL] [Abstract][Full Text] [Related]  

  • 118. An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers.
    Heil SH; Linares Scott T; Higgins ST
    Drug Alcohol Depend; 2009 Oct; 104 Suppl 1(Suppl 1):S106-14. PubMed ID: 19540679
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Gestational age at enrollment and continued substance use among pregnant women in drug treatment.
    Terplan M; Garrett J; Hartmann K
    J Addict Dis; 2009; 28(2):103-12. PubMed ID: 19340672
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Prenatal exposure to drugs: effects on brain development and implications for policy and education.
    Thompson BL; Levitt P; Stanwood GD
    Nat Rev Neurosci; 2009 Apr; 10(4):303-12. PubMed ID: 19277053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.